4D Cardiac Nucleome Maps Nuclear and Chromatin Dynamics in Health and Aging

The nucleus is a layered, moving control center whose organization—from nucleosome positioning to chromatin domains and large-scale 3D genome architecture—governs how genes are turned on or off. When these changes are tracked across time, the result is a “4D nucleome,” a dynamic landscape that allows transcription to respond precisely to cellular context. In the heart, this time-dependent architecture helps coordinate the gene-expression programs that shape lineage choices, generate cardiac cell types, and sustain function long after development. As cells transition from embryonic stages to mature states, and later into disease or aging programs, the genome is reorganized rather than merely read out.

New findings synthesize evidence that shifts in nuclear architecture align with coordinated changes in chromatin accessibility and transcription factor occupancy. In other words, remodeling the physical and epigenetic neighborhood of DNA helps determine which regulatory sites are available when. These remodeling events create stable yet adaptable states, enabling heart cells to mount appropriate transcriptional responses as conditions change.

The review emphasizes that nuclear organization is not static. Over developmental time, chromatin moves and domains reorganize, reshaping enhancer–promoter communication and thereby modulating lineage commitment. During disease progression, similar principles reappear: altered 3D genome topology and epigenetic marks accompany aberrant gene-expression programs. Aging adds another layer, with progressively remodeled chromatin states that can change how regulatory networks respond to stress.

Importantly, genome organization is shaped by inputs beyond genetics. Mechanical cues—such as changes in tissue stiffness and nuclear tension—can influence chromatin compaction, nuclear positioning, and accessibility. Metabolic signals also feed into epigenetic regulation, altering the availability of chromatin-modifying substrates and the activity of epigenetic enzymes.

By framing the heart’s genome as a 4D system, the authors argue that understanding these coupled mechanical, metabolic, and architectural controls could reveal disease mechanisms that are otherwise invisible when studying DNA regulation alone. Such insights may guide regenerative strategies that rebuild appropriate chromatin states and support precision cardiovascular medicine. The Review also outlines emerging approaches to interrogate nuclear structure and chromatin dynamics, including technologies designed to map chromatin interactions in space and track how they change over time.

Ultimately, deciphering the cardiac 4D nucleome promises a mechanistic bridge between genome organization and clinical outcomes—connecting transcriptional control to development, degeneration, and adaptive resilience. As nuclear and chromatin dynamics become measurable in increasingly detail, they may also become actionable targets in future therapies.